Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
1 July 2024
m 00:49 | Atezolizumab (Tecentriq) diffhist +2 Warner-admin talk contribs Text replacement - "http://www.gene.com/" to "https://www.gene.com/" |
m 00:49 | Bevacizumab (Avastin) diffhist +3 Warner-admin talk contribs Text replacement - "http://www.gene.com/" to "https://www.gene.com/" |
30 June 2024
28 June 2024
27 June 2024
m 21:36 | Levels of Evidence diffhist -10 Jwarner talk contribs |
|
m 11:23 | Small cell lung cancer 2 changes history +472 [Jwarner (2×)] | |||
m |
|
11:23 (cur | prev) -521 Jwarner talk contribs | |||
m |
|
11:19 (cur | prev) +993 Jwarner talk contribs →Topotecan monotherapy {{#subobject:6e9625|Regimen=1}} |
23 June 2024
15 June 2024
m 09:33 | Stub diffhist -3 Jwarner talk contribs →ddFEC |
|
m 00:29 | Durvalumab (Imfinzi) 3 changes history +314 [Jwarner (3×)] | |||
m |
|
00:29 (cur | prev) 0 Jwarner talk contribs | |||
m |
|
00:27 (cur | prev) +53 Jwarner talk contribs | |||
m |
|
00:25 (cur | prev) +261 Jwarner talk contribs →History of changes in FDA indication |